BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7643449)

  • 21. Leukemogenesis caused by incapacitated GATA-1 function.
    Shimizu R; Kuroha T; Ohneda O; Pan X; Ohneda K; Takahashi S; Philipsen S; Yamamoto M
    Mol Cell Biol; 2004 Dec; 24(24):10814-25. PubMed ID: 15572684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct mechanisms direct SCL/tal-1 expression in erythroid cells and CD34 positive primitive myeloid cells.
    Bockamp EO; McLaughlin F; Göttgens B; Murrell AM; Elefanty AG; Green AR
    J Biol Chem; 1997 Mar; 272(13):8781-90. PubMed ID: 9079714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SCL gene in human tumors.
    Rockman S; Begley CG; Kannourakis G; Mann GJ; Dobrovic AN; Kefford RF; McGrath K
    Leukemia; 1992 Jul; 6(7):623-5. PubMed ID: 1625484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GATA-1 is expressed in acute erythroblastic leukaemia.
    Ekert H; Sievers EL; Tan A; Martin DI; Smith FO; Barnard D; Bernstein ID
    Br J Haematol; 1994 Feb; 86(2):410-2. PubMed ID: 8199039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GATA-1 but not SCL induces megakaryocytic differentiation in an early myeloid line.
    Visvader JE; Elefanty AG; Strasser A; Adams JM
    EMBO J; 1992 Dec; 11(12):4557-64. PubMed ID: 1385117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of GATA transcription factors in myelogenous and lymphoblastic leukemia cells.
    Minegishi N; Morita S; Minegishi M; Tsuchiya S; Konno T; Hayashi N; Yamamoto M
    Int J Hematol; 1997 Apr; 65(3):239-49. PubMed ID: 9114595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of GATA-2 Gene and Immunoglobulin Heavy Chain Germline Gene C( micro ) in Leukemia Cells and Its Significance].
    Wang L; Dong L; Liu G; Hu L; Jiang M; Jia S; Lu S; Chen H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2000 Sep; 8(3):176-179. PubMed ID: 12578677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of a lineage specific transcriptional factor GATA-1 in leukaemic blasts from patients with infantile leukaemia.
    Ito E; Toki T; Arai K; Kawauchi K; Tsuda H; Yokoyama M
    Br J Haematol; 1992 Apr; 80(4):561-3. PubMed ID: 1581244
    [No Abstract]   [Full Text] [Related]  

  • 29. GATA1 mutation analysis demonstrates two distinct primary leukemias in a child with down syndrome; implications for leukemogenesis.
    Hellebostad M; Carpenter E; Hasle H; Mitchell C; Vyas P
    J Pediatr Hematol Oncol; 2005 Jul; 27(7):408-9. PubMed ID: 16012335
    [No Abstract]   [Full Text] [Related]  

  • 30. Purification of leukemic blast cells from blood smears using laser microdissection.
    Matsuo H; Shiga S; Imai T; Kamikubo Y; Toki T; Terui K; Ito E; Adachi S
    Int J Hematol; 2017 Jul; 106(1):55-59. PubMed ID: 28409329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic Vulnerabilities of Transcription Factors in AML.
    Khan I; Eklund EE; Gartel AL
    Mol Cancer Ther; 2021 Feb; 20(2):229-237. PubMed ID: 33158995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Classification of the acute leukemias.
    McKenna RW
    Minn Med; 1984 Sep; 67(9):487-90. PubMed ID: 6593577
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapy Response and Outcome Explained by Leukemia Cell of Origin.
    Gu Z; Dickerson KE; Xu J
    Cancer Discov; 2020 Oct; 10(10):1445-1447. PubMed ID: 33004477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GATA 2 Haploinsufficiency in Acute Myeloid Leukemia: Looking Beyond the Obvious.
    Radhakrishnan N; Singh S; Nath D; Madan J
    Indian Pediatr; 2020 Jun; 57(6):570-571. PubMed ID: 32562402
    [No Abstract]   [Full Text] [Related]  

  • 35. Application of GATA-3 gene marker in the detection of hematologic disorders in children.
    Wang F; Bie L
    Exp Ther Med; 2018 Feb; 15(2):1879-1885. PubMed ID: 29434778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic challenge in a case of ambiguous lineage acute leukemia with PICALM::MLLT10 rearrangement.
    Quessada J; Petit A; Saultier P; Fenwarth L; Marceau-Renaut A; Arnoux I; Payet-Bornet D; Michel G; Lafage M; Loosveld M
    Pediatr Blood Cancer; 2023 Nov; 70(11):e30573. PubMed ID: 37439579
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute erythroid leukemias have a distinct molecular hierarchy from non-erythroid acute myeloid leukemias.
    Cervera N; Lhoumeau AC; Adélaïde J; Guille A; Murati A; Mozziconacci MJ; Vey N; Birnbaum D; Gelsi-Boyer V
    Haematologica; 2020 Jul; 105(7):e340-e342. PubMed ID: 31601691
    [No Abstract]   [Full Text] [Related]  

  • 38. No evidence for microsatellite instability in acute myeloid leukemia.
    Walker CJ; Eisfeld AK; Genutis LK; Bainazar M; Kohlschmidt J; Mrózek K; Carroll AJ; Kolitz JE; Powell BL; Wang ES; Stone RM; Bundschuh R; de la Chapelle A; Bloomfield CD
    Leukemia; 2017 Jun; 31(6):1474-1476. PubMed ID: 28336936
    [No Abstract]   [Full Text] [Related]  

  • 39. IKAROS and MENIN in synergy in AML.
    Jones LM; Starczynowski DT
    Nat Cancer; 2022 May; 3(5):528-529. PubMed ID: 35624338
    [No Abstract]   [Full Text] [Related]  

  • 40. Erratum: Group 3 innate lymphoid cells continuously require the transcription factor GATA-3 after commitment.
    Zhong C; Cui K; Wilhelm C; Hu G; Mao K; Belkaid Y; Zhao K; Zhu J
    Nat Immunol; 2016 Feb; 17(2):214. PubMed ID: 26784267
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.